What Should Clinicians Know About Dietary Supplement Quality?
Sign Up to like & getrecommendations! Published in 2022 at "AMA journal of ethics"
DOI: 10.1001/amajethics.2022.382
Abstract: Increase in dietary supplement use in the United States suggests a great need for clinicians to be aware of the range of supplements' quality parameters. Regulatory requirements exist, but specific quality parameters for each ingredient… read more here.
Keywords: know dietary; quality; clinicians know; dietary supplement ... See more keywords
McGirt v Oklahoma and What Clinicians Should Know About Present-Day Child Abuse and Legacies of Forced Migration.
Sign Up to like & getrecommendations! Published in 2023 at "AMA journal of ethics"
DOI: 10.1001/amajethics.2023.123
Abstract: In 1997, Jimcy McGirt was convicted by the State of Oklahoma for sex crimes against a minor. McGirt appealed his conviction, citing that Oklahoma lacked jurisdiction over the case due to his tribal citizenship, since… read more here.
Keywords: child abuse; oklahoma clinicians; clinicians know; mcgirt oklahoma ... See more keywords
What should clinicians know about the renal effect and the mechanism of action of levosimendan?
Sign Up to like & getrecommendations! Published in 2021 at "Expert Opinion on Drug Safety"
DOI: 10.1080/14740338.2021.1986483
Abstract: Recently, some trials challenged the favorable consequences of levosimendan toward renal function. A recent meta-analysis by Long et al. evaluated 28 studies in 5,069 patients [1]. Levosimendan reduced the serum creatinine (sCr) and the risk… read more here.
Keywords: know renal; effect mechanism; action levosimendan; clinicians know ... See more keywords
Factor XI inhibitors: what should clinicians know
Sign Up to like & getrecommendations! Published in 2022 at "Current Opinion in Cardiology"
DOI: 10.1097/hco.0000000000001015
Abstract: Purpose of review Factor XI (FXI) inhibitors were developed to address unmet needs and limitations of current anticoagulants and are currently being studied in several indications. In this paper, we review the rationale for the… read more here.
Keywords: inhibitors clinicians; fxi inhibitors; factor inhibitors; clinicians know ... See more keywords
What Clinicians Should Know About Surrogate Endpoints in Hematologic Malignancies.
Sign Up to like & getrecommendations! Published in 2024 at "Blood"
DOI: 10.1182/blood.2023022269
Abstract: Use of surrogates as primary endpoints is commonplace in hematology/oncology clinical trials. As opposed to prognostic markers, surrogates are endpoints that can be measured early and yet can still capture the full effect of treatment,… read more here.
Keywords: know surrogate; hematologic malignancies; hematology; clinicians know ... See more keywords